The shift towards providing high value cancer care has placed increasing importance on patient experiences. This scoping review summarizes patient experience literature, highlights research gaps, and provides future research directions. We then introduce a new resource that links the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) program with the Centers for Medicare and Medicaid Services Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey and longitudinal medical claims data. We conducted a scoping review to identify relevant research within the Medicare CAHPS domain that examine factors associated with patient-reported experiences with their cancer care. Gaps indicate a need for population-based research to explore relationships between cancer patient experiences, healthcare utilization, and subsequent patient outcomes. SEER-CAHPS, a publicly accessible data resource, may assist in addressing these gaps by linking cancer registry (SEER), survey data reported by Medicare beneficiaries (CAHPS), and Medicare claims, providing unique insight into quality of care. Linked data include 231,089 surveys from patients with a cancer diagnosis, and 4,236,529 surveys from patients without a cancer diagnosis. Results indicate substantial gaps in our knowledge of patient experiences and the need for additional resources. SEER-CAHPS links direct patient feedback with cancer registry and Medicare claims, making it an important source of information on experiences and healthcare utilization. Increasing recognition of the importance of patient-centeredness points to the need for population-based studies. Findings from SEER-CAHPS will inform initiatives to improve care delivery.
Introduction
There are an estimated 15.5 million cancer survivors in the United States, and this number is projected to increase to almost 26.1 million by 2024, including 73% of survivors older than the age of 65 1 . While advances in diagnostic and treatment capabilities have greatly increased survival for many cancers, increasing attention is needed on the experiences of cancer patients, both during and after treatment. The Triple Aim outlines three interdependent goals for improving the quality of the U.S. healthcare system: improving health outcomes, reducing healthcare costs, and improving the experience of care 2 .
The focus on patient experience has accompanied a shift in clinical practice toward a model of patient-centered cancer care delivery 3, 4 . While there are varied definitions, Wolf and colleagues 3 posit that "patient experience" captures a more specific measurement of patient care than satisfaction, and Price and colleagues 5 add that patient experiences can refer to any observable process, both subjective or objective, reflecting specific components of care from the patient's perspective. Experience also includes the complex relationship of patient knowledge, values, and expectations of care. Research has noted several challenges in relying exclusively on patient satisfaction as a metric for quality, most notable that it is often influenced by proximal, unrelated outcomes [6] [7] [8] While research has indicated the importance of patient experience, there is a need for an in-depth examination of the literature to define gaps in understanding specific to cancer care. While we acknowledge that there are multiple ways to review a scientific area, we chose to conduct a scoping review, which allows identification of the extent, nature, and range of a given research area, as well as existing gaps. In contrast with systematic reviews, scoping reviews focus more on describing a broader research area rather than providing a synthesis on a narrower scientific topic.
Saunders and colleagues 9 performed a comprehensive review of cancer patient experience measures. While our scoping review is informed by this work, we chose to focus on core domains of patient experiences reflected in the Medicare CAHPS surveys, which were not included in the prior review. These domains include doctor/patient communication, coordination of care, getting needed care and getting care quickly (grouped as access to care for the current paper), quality of care/provider, quality of health plan, prescription drug plan customer service, and getting needed prescription drugs. The purpose of this study was to explore these key components of cancer patient experiences, including the identification of gaps and potential future research questions that could be answered using new data resources. We conclude with the introduction of a new resource that links the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) program with the Centers for Medicare and Medicaid Services Consumer Assessment of Healthcare Providers and Systems (CAHPS ® ) survey and longitudinal claims data.
Approach and Methods
We used the scoping methodology proposed by Arksey and O'Malley, 10 with additional attention to recommendations from Levac and colleagues 11 . The 6 steps of a scoping review have been outlined as: (1) identify a clear research question; (2) search for relevant studies; (3) select studies; (4) chart the data; (5) collate, summarize, and report results; and (6) consult with stakeholders to contextualize and inform overall findings. Unlike systematic reviews, scoping reviews do not provide a standardized quality assessment of studies. Instead, scoping reviews typically include a summary of exemplary papers and identify areas for future research.
We used PubMed and CINAHL to search the literature for studies published between 2005 and 2016, focusing on cancer patient experiences with care using the term cancer (or neoplasm) in combination with search terms found in Figure 1 . The research team developed search terms a priori to reflect both core concepts cited in the patient experiences literature and a focus on domains included in the Medicare CAHPS surveys. We refined terms as needed using an iterative process. Articles were included if they explored an aspect of patient experience as a predictor or outcome variable and/or included patient-reported outcomes related to experiences with care in one of our five targeted domains (doctor communication, care coordination, access to care, patient perceptions of care quality, and other aspects of care, including prescription drug plan and customer service) In addition, while we recognize the distinction between satisfaction and experience, we chose to include studies of satisfaction when they focused on a specific aspect of patient care. Figure 2 shows the flow of articles through the selection process. Initial searches of the PubMed and CINAHL peer-reviewed literature databases resulted in 2,046 citations. After limiting to randomized trials, observational studies (including quantitative, qualitative, and mixed-methods studies), and reviews published in English, 449 citations remained.
A review and screening of titles and abstracts for adherence to inclusion criteria resulted in 48 citations. The vast majority were not included because they were not specific to cancer care. Two authors then independently reviewed the full text of the remaining articles, resulting in the exclusion of an additional 29 studies. Bibliographies of the articles in this subset (n=19) were then manually scanned to identify additional papers missed in previous literature searches, adding 4 studies. The inclusion of the final subset of 23 articles were confirmed by three authors to ensure adherence to inclusion criteria.
Data from the final set of studies were then abstracted and articles were categorized based on 5 areas of interest: (1) doctor/patient communication, (2) care coordination, (3) access to care, (4) patient perceptions of care quality, and (5) other aspects of patient experience. When studies spanned more than one category, we focused on the main outcome as stated in the study objective. Groupings of these articles were confirmed by an additional reviewer.
The following data were extracted and summarized in 
Results
A total of 23 published articles met the inclusion criteria, including 1 randomized controlled trial, 11 observational studies, 6 reviews, and 5 qualitative or mixed methods studies. Table 1 summarizes the study objectives, sample characteristics, outcomes, and main findings for each included study. 
Patient-Provider Communication

Care Coordination
Six studies identified in the review examined care coordination: 1 randomized trial, 2 observational studies, 1 systematic review (n=4), and 2 qualitative/mixed-methods studies. Many studies included multiple cancer types [16] [17] [18] [19] , one focused on breast cancer 20 , and another on colorectal cancer 21 . Topics explored included perceptions of the critical components of care coordination 16, 18, 20 and the effectiveness of follow-up care delivery models, including nurse-led versus physician, and oncology versus primary care 17, 19, 21 . Identified facilitators of coordinated care included patient navigation, effective communication among treatment team providers, and providing sufficient and timely information to patients 16, 20 . Barriers reported as affecting a patient's perception of care coordination included limited patient health literacy and obstructed access to the healthcare system 20 . Gaps in coordination in both visits with and communication between primary care providers and oncologists could result in delays in appropriate treatment and follow-up care 19 . In addition, two studies suggest that nurse-led follow-up care may be as effective in influencing patient experience as oncologistled models 17, 21 . 
Access to Care
Patient Perceptions of Care Quality
Health Plan Quality: Nine papers that focused on patient perceptions of care quality were included in the review, including 5 observational studies and 4 literature reviews. 28 examined associations between MA star ratings and plan enrollment and determined that an increase of 1 star was associated with 9.5% increase in likelihood to enroll. The authors also found that star ratings were less strongly associated with enrollment for black, rural, low-income, and younger beneficiaries. Xu and colleagues 29 investigated whether MA contract characteristics are associated with quality of care through star ratings and determined that nonprofit (vs. for-profit), larger, and older MA contracts were more likely to receive higher star ratings. An additional study assessed associations between MA plan attributes (cost, quality, and benefits) and beneficiary enrollment, finding that preference for higher quality and lower-cost MA plans with diminishing differences at higher star ratings of 4 and 5 27 .
Healthcare Provider Quality: A systematic review of 11 studies of patient perceptions of healthcare providers (specifically physicians) identified the constructs of loyalty, personal care, trust, and continuity as important guiding principles for assessing patient perceptions of provider quality. This review pointed toward the need for longitudinal research to further characterize the important attributes of patient-provider relationships. 30 . An additional systematic review of 44 studies of provider/institution-level factors and outcomes in ovarian cancer patients concluded that discipline and subspecialization of primary treating physician conferred the biggest impact on survival and suggested improving trends in patient experience over time 31 .
End-of-life Care Quality: Two papers focused on quality of end-of-life care are noteworthy. One study conducted within the Veteran's Health Administration determined key areas of quality that should be assessed: addressing patient well-being and dignity, providing adequate health information and communication; providing emotional and spiritual support; providing care around time of death, availing access to supportive services before the death, and providing access to benefits and services after the patient's death 32 . Finally, a narrative review identified referral to hospice within the last few days of life as a potential indicator of patient-perceived poor quality care 33 .
Other Aspects of Patient Experience including Prescription Drug Plan and Customer Service
Our review did not identify studies exploring potential additional drivers of patient experience, such as healthcare customer service. One cross-sectional study did explore potential drivers of older adult patients' experience with prescription drug plans 34 , looking at associations between the practice of prescribing and utilization of high risk medications and Medicare Part D CMS star ratings for composites including "Getting Needed Prescription Drugs," "Complaints about Drug Plan," "Rating of Drug Plan," and "Members Choosing to Leave the Plan." Medicare Star Ratings assess the performance of contracted health and drug plans on indicators of care access, clinical quality, member satisfaction, and customer service. Erickson and colleagues observed weak but significant associations between high-risk medications and "Getting Prescription Drugs," suggesting that high-risk medication usage is likely only one of many factors influencing overall member experience. The authors suggest that members may also place importance on perceived cost burdens when rating their prescription drug plans. It is also important to note that this study did not test for associations with actual utilization of prescription drug plans and subsequent health outcomes, a potential area for future research.
Summary and Implications from Scoping Review
We conducted this scoping review to identify gaps in the literature exploring specific factors related to patient experience in cancer care. Although a considerable amount of research has been done on patient experience, our review identified several important areas for future research. In general, there were few studies focusing on the associations between experience and outcomes including healthcare utilization, cost, adherence to guideline-concordant care, and patient health outcomes. As reimbursement models shift from pay for volume to pay for performance, there is increasing recognition of the importance of incorporating patient experiences in the definition of value 35 . It is essential to connect patient experiences with such outcomes to comprehensively define value.
Our analysis pointed to several important areas for future research, particularly in the areas of care coordination, Much of the previously published literature on perceived access to care focuses on access to follow-up after abnormal diagnostic results and subsequent survival. Gaps remain in our understanding of relationships between a patient's perceptions of access to care and adherence to cancer treatment and surveillance for recurrence and secondary cancers. Access to care has implications at all phases of the cancer care continuum, impacting outcomes from screening to diagnosis and treatment 39 . Further research is necessary to define the effect of access beyond initial treatment, including survivorship and palliative care. Our review also indicates a need for longitudinal research to further characterize the effects of patient-provider relationships on the quality of healthcare. Patients, particularly older adults, are being offered a growing number of healthcare plan choices, which further increases the importance for patient-perceived quality reporting and evaluation 40 . It is thus essential to investigate the effect of quality ratings on healthcare utilization. The role of health plan and care quality for underserved and vulnerable cancer patients also warrants further investigation. Finally, there were few studies on other important aspects of patient experience, including healthcare customer service. Patients often face difficulties in completing paperwork and managing the administrative aspects of their care, including challenges in reaching their providers by telephone, unresponsiveness of office staff, and an increasing number of forms to fill out. These barriers can deter subsequent care-seeking and affect outcomes such as adherence to treatment and symptom reporting. We found no studies examining cancer patient experiences with provider and health plan customer service nor its relation to adherence through treatment and survivorship.
The results reported here are subject to certain limitations. First, the emphasis of the scoping review on concepts assessed by the CAHPS survey necessarily resulted in the exclusion of large subsets of the patient experience literature. In addition, this scoping review was limited to studies published in English since 2005, and focused on studies in North America.
New Research Resource to Examine Cancer Patient Experiences with Care: SEER-CAHPS
Overall, our review indicated that data resources are needed to explore both drivers and outcomes of patient experiences with cancer care. SEER-CAHPS is one such resource that could provide a great deal of information in each of these areas. The SEER-CAHPS linkage has been previously described by Chawla and colleagues 41 . Tables 4a and 4b . In addition, we acknowledge that data resources are not the only method to explore patient experiences. This resource, however, has a unique ability to answer questions using a populationbased sample. Overall, SEER-CAHPS is a comprehensive source of information that provides the opportunity to link patient experiences with healthcare outcomes and compare individuals with and without cancer.
Summary
With increasing numbers of older adults living with cancer, receiving complex treatments, and dealing with complex and fragmented healthcare systems, studies of cancer patients' experiences are timely and imperative. This scoping review has highlighted key areas for future research on patient experiences, including key research questions that can be answered using a new linked data resource. SEER-CAHPS is a unique resource that can be used to understand cancer care delivery and the impact on patient outcomes at all phases of the cancer care trajectory. It also has the potential to assist healthcare systems and policy makers in improving the quality of care for Medicare beneficiaries with cancer. • Does perception of care coordination predict adherence to follow-up care in cancer survivors?
• Does perception of care coordination vary based on cancer phase (post diagnosis, treatment, in last year of life)?
• Does perception of care coordination vary by cancer treatment modality? Access to Care
• Is perceived access to care associated with time between diagnosis and first course of cancer treatment?
• Do patient experiences with care mediate the association between race/ethnicity and survival across cancer types?
• Does type of healthcare provider seen predict perceived timeliness of care for cancer patients? Patient Perceptions of Care Quality
• Do cancer patient experiences with quality predict subsequent healthcare utilization?
• Does perceived quality of provider vary by cancer type? Other Aspects of Patient Experience
• Do experiences with prescription drug plan predict adherence to cancer treatment?
• Do experiences with getting prescription drugs predict overall survival for cancer patients?
• Do cancer patient experiences with customer service vary across urban and rural settings?
*Analyses of some of these topics may require additional linkages by investigators. In addition, availability of data to answer given research questions varies across cancer sites and years of diagnosis. 
